SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

BACKGROUND: SARS-CoV-2 antibody testing is required for estimating population seroprevalence and vaccine response studies. It may also increase case identification when used as an adjunct to routine molecular testing. We performed a validation study and evaluated the use of automated high-throughput...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Virol
Main Authors: Sekirov, Inna, Barakauskas, Vilte E., Simons, Janet, Cook, Darrel, Bates, Brandon, Burns, Laura, Masud, Shazia, Charles, Marthe, McLennan, Meghan, Mak, Annie, Chahil, Navdeep, Vijh, Rohit, Hayden, Althea, Goldfarb, David, Levett, Paul N, Krajden, Mel, Morshed, Muhammad
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282439/
https://ncbi.nlm.nih.gov/pubmed/34304088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2021.104914
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados